Literature DB >> 23609413

Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease.

Stephanie Mathews1, Bin Gao.   

Abstract

Entities:  

Year:  2013        PMID： 23609413      PMCID： PMC3786181          DOI： 10.1002/hep.26336

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  13 in total

Review 1.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

Review 2.  The inflammasome: an integrated view.

Authors:  Olaf Gross; Christina J Thomas; Greta Guarda; Jurg Tschopp
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 3.  Sterile inflammation in the liver.

Authors:  Paul Kubes; Wajahat Z Mehal
Journal:  Gastroenterology       Date:  2012-09-13       Impact factor: 22.682

4.  Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice.

Authors:  M Yin; M D Wheeler; H Kono; B U Bradford; R M Gallucci; M I Luster; R G Thurman
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

Review 5.  Inflammasomes in liver diseases.

Authors:  Gyongyi Szabo; Timea Csak
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

Review 6.  Inflammation in alcoholic liver disease.

Authors:  H Joe Wang; Bin Gao; Samir Zakhari; Laura E Nagy
Journal:  Annu Rev Nutr       Date:  2012-04-18       Impact factor: 11.848

7.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

8.  A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.

Authors:  Nicholas C Boetticher; Craig J Peine; Paul Kwo; Gary A Abrams; Tushar Patel; Bashar Aqel; Lisa Boardman; Gregory J Gores; William S Harmsen; Craig J McClain; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2008-09-13       Impact factor: 22.682

Review 9.  Treatment of alcoholic liver disease.

Authors:  Ashutosh Barve; Rehan Khan; Luis Marsano; Kadiyala V Ravindra; Craig McClain
Journal:  Ann Hepatol       Date:  2008 Jan-Mar       Impact factor: 2.400

Review 10.  IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.

Authors:  Jan Petrasek; Shashi Bala; Timea Csak; Dora Lippai; Karen Kodys; Victoria Menashy; Matthew Barrieau; So-Yun Min; Evelyn A Kurt-Jones; Gyongyi Szabo
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808
View more
  15 in total

1.  Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.

Authors:  Terence N Bukong; Arvin Iracheta-Vellve; Banishree Saha; Aditya Ambade; Abhishek Satishchandran; Benedek Gyongyosi; Patrick Lowe; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2016-07-22       Impact factor: 17.425

2.  New drug targets for alcoholic liver disease.

Authors:  Mingjiang Xu; Binxia Chang; Stephanie Mathews; Bin Gao
Journal:  Hepatol Int       Date:  2014-03-08       Impact factor: 6.047

Review 3.  Targeting inflammation for the treatment of alcoholic liver disease.

Authors:  Ming-Jiang Xu; Zhou Zhou; Richard Parker; Bin Gao
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

Review 4.  Fibrogenesis in alcoholic liver disease.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

5.  The role of human cytochrome P450 2E1 in liver inflammation and fibrosis.

Authors:  Jun Xu; Hsiao-Yen Ma; Shuang Liang; Mengxi Sun; Gabriel Karin; Yukinori Koyama; Ronglin Hu; Oswald Quehenberger; Nicholas O Davidson; Edward A Dennis; Tatiana Kisseleva; David A Brenner
Journal:  Hepatol Commun       Date:  2017-10-30

6.  Time-Course Evaluation of Iminodipropionitrile-Induced Liver and Kidney Toxicities in Rats: A Biochemical, Molecular and Histopathological Study.

Authors:  Manar A Alwelaie; Mohsen G Al-Mutary; Nikhat J Siddiqi; Maha M Arafah; Abdullah S Alhomida; Haseeb A Khan
Journal:  Dose Response       Date:  2019-05-23       Impact factor: 2.658

7.  Granulocytic myeloid-derived suppressor cell population increases with the severity of alcoholic liver disease.

Authors:  Miaomiao Gao; Ang Huang; Zijian Sun; Ying Sun; Binxia Chang; Ji-Yuan Zhang; Zheng-Sheng Zou
Journal:  J Cell Mol Med       Date:  2018-12-25       Impact factor: 5.310

Review 8.  Update on Alcoholic Hepatitis.

Authors:  Natalie J Torok
Journal:  Biomolecules       Date:  2015-11-02

Review 9.  Role of interleukin-22 in liver diseases.

Authors:  Chun-xiao Pan; Jie Tang; Xiao-yu Wang; Fan-rong Wu; Jin-fang Ge; Fei-hu Chen
Journal:  Inflamm Res       Date:  2014-03-13       Impact factor: 4.575

Review 10.  Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical Trials.

Authors:  Tao Zeng; Cui-Li Zhang; Mo Xiao; Rui Yang; Ke-Qin Xie
Journal:  Front Immunol       Date:  2016-11-29       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.